Welcome to our blog

Read our latest marketing tips and scientific industry news

Merry Christmas 2019 Onyva The Agency

Merry Christmas from the Onyva Team

Let the festivities begin!

We wish all our friends and colleagues the very best for the festive season! We hope you have a great break if you’re celebrating. It’s been a busy year for all of our team and we’re looking forward to a little down time. We wanted to say a special thank you to our great clients in 2019, that have kept us busy! In 2020, we’ll be launching a new series of marketing tips and new podcasts for the life sciences, biotech and scientific technical sector. Feel free to email us, if there are any specific topics you’d like us to cover. We’ll be launching survey’s online too.

We like to give something back and our two chosen charities for 2020 are the Motor Neurone Disease Association (MNDA) — who are doing great things for research and helping sufferers, and Petals – The baby loss counselling charity.

Best Wishes from,

Seema Sharma & the Onyva The Agency Team.

Pioneering women in science IWD2019

Pioneering Women in Science 2019

In honour of International Women’s Day 2019 and Women in Science day, both falling in March this year, we’d like to thank and acknowledge all of the pioneering women who’ve advanced scientific discovery through a dedicated infographic. Women are still underrepresented in STEM, so we hope that these scientists serve to inspire others through the significant contributions they have, and will continue to make.

Read our relevant content articles for Women in STEM for Mendeley:

 Gender Bias in the Workplace: Practical Steps for change by Seema Sharma

Women in Tech: Pioneers, past and present by Seema Sharma

Email Marketing Life Sciences

Email marketing for the scientific sector: A practical guide

by Seema Sharma

Email Marketing Stage 1: Establishing subscribers, content ideas and platforms

In our next series of blog posts, we’ll be covering practical approaches to email marketing for the scientific sector, which include the life sciences and related biotech, pharmaceutical and medical diagnostics fields. In this post, we’ll take a look at establishing your list, content ideas for the scientific sector, prerequisites for a good digital strategy, and platforms to consider. Our next articles will cover, content, layouts, A/B testing, KPI’s and metrics.

Background and key groundwork

B2B email marketing in the life sciences and related sectors, requires critical differences in approach to the B2C and retail areas to be effective. A strong content hub, relevant to your scientific audience is a critical prerequisite to an effective email campaign. You should include content thats relevant to all of the personas that are interested in your product offering. In fact, identifying your target customers, their demographics and personas, including a typical journey to purchase, is a critical task for planning your entire digital marketing strategy — including email.

If you don’t know who your customers are, or their buying habits — finding that out is your first crucial step in the process. Typical customers could include academic researchers, industry researchers, clinicians and lab managers, amongst others, dependent on your company offering. They may need further subdivision if they intersect with different research focusses, clinical specialisms or stage of career. If you have sufficient numbers of each intersect – you need to produce tailored or specialised content that is deemed valuable to that demographic.

 

‘Identifying your target customers, their demographics and personas, including a typical journey to purchase, is a critical task for planning your entire digital marketing strategy.’

To be the most effective, subscribers should be expecting to receive an email from you, having opted in actively. Note that the forms and opt-in need to be compliant with the data laws in your country, (GDPR compliant opt-in and emailing is required in the UK!).

Email capture and content ideas

Establishing your list requires a clear understanding of who you want to engage and capture as a subscriber. A good approach is to use a ‘give-away’ that is relevant to them. ‘Give-away’ is used in the broad sense here, to mean anything from your content hub that they would find useful. For those of you that like inbound terminology – this is sometimes referred to as ‘top of the funnel content.’
Some online content ideas for the life sciences or scientific sector include:
Email icon

  • Industry-specific reports
  • e-books / blog posts on recent scientific research developments
  • Webinar access
  • Research or clinical training video access
  • How-to technical summaries or research methodology guides
  • Posters, including pathways or disease mechanisms
  • New research discoveries and summary infographics
  • Interactive competitions that have research relevant prizes

to name a few…..

The latter all need to be posted on a landing page, with a plan to drive traffic to that page. Gating this content to include an email capture form that allows for key demographics, (e.g name, job, title, research field or clinical specialism and permission to contact etc.,), is a great way to expand and establish your subscriber list.
SEO optimisation of your landing page will help it perform well organically. Promoting it through existing channels, like Social Media accounts can help spread the word and will ensure you have an integrated approach to your marketing across channels.

You can also use a PPC (pay per click) approach here, using Google adwords, or Social Media advertising (promoted tweets, facebook ads etc.,). However, be sure to do an A/B test to optimise the format and wording that performs best, and set a small budget in the first instance. This will allow you to gauge performance against parameters for quality leads, before committing to a full campaign. Not doing so can mean you have sub-optimal performance and can heavily overspend very rapidly.

Some offline ideas to expand your subscriber list include:

  • Organising events with key speakers on relevant research topics and including opt-in forms as part of the registration process.
  • Alternatively, exhibition leads who opt-in at your booth in return for a give-away or competition.

Deciding between email providers

There are an ever increasing range of email platforms available on the market, that claim to solve all your email marketing problems. The current trend is for complete marketing automation solutions that cover all digital touch points with customers (email, social, web and mobile app communications). They include email marketing as part of the offering.

Key considerations when selecting an email provider or marketing automation software:

    • Your budget
    • Ease of integration with existing CRM systems
    • The complexity of your emailing. (Some platforms only allow for a certain level of complexity).
    • Road test a free version thoroughly, (if its available).
    • Use recommendations — Do you know someone else that’s used a platform? Chat to them about the pros and cons of using it and any headaches they encountered.
    • Data considerations – I recently worked with a client whose promise to its customers was that their data would not be transferred outside of Europe. As such, we had to exclude many platforms, as many data servers are housed in the US.
    • Level of HTML and IT expertise in-house — Most platforms will require a certain level of HTML knowledge to allow for the creation of a unique template that will appeal to your target customers. There are off the shelf-templates in many platforms, that allow for drag and drop template design with reasonably straight-forward UI’s, but they will most likely need customisations to fit your branding, content and layout needs. Some platform providers have in-house template development and support as an add-on cost.
      Note, they’ll also be basic things to do on your site like DNS entries, to ensure the email is coming from your domain, alongside this. Also, if you are at the larger company end of the spectrum, and have other platforms in-house like Salesforce or an alternative CRM system, you’ll need to consider how to integrate your chosen email platform with it.

Email platforms to consider

(NB: This list is not exhaustive and in no particular order. Monthly subscription costs of the most basic package available are shown in brackets)
Mobile email icon

MailChimp

 

            1. (Free for <1000 subscribers)

Hubspot

            1. ($200)

Marketo

            1. ($895)

Oracle Eloqua

            1. ($2000 for <10K contacts)

Campaign Monitor

            1. (£9 <2500 subscribers)

Adobe Campaign

            1. (Pricing information not available)

Pardot by Salesforce

            1. ($1250 for <10,000 subscribers)

Zoho Campaign

            1. (Tiered according to subscribers/emails.Prices start at $3 for <500 emails)

Emma

            1. ($49)

dotMailer

            1. (£250)

Get Response

            1. ($15)

Active Campaign

            1. ($9)

Red Cappi

            1. ($10 < 500 subscribers)

NewZapp

            1. (£80)

Newsletters2Go

            1. (free basic plan or $20 per month with more functionality)

Email Templates and Layout

Your layout should be reflective of your company’s brand and instantly recognisable as coming from you. A strongly branded header and footer can help with the latter. It’s tempting to add a lot of text heavy technical content into individual emails if you work in marketing the life sciences, or related Biotech and Pharma fields, but incorporating several images is crucial to make your content appealing.

Subscribers like to click on images and they help considerably as content teasers. Consider what these images might routinely be for your company, (e.g product images, research data and graphs, cellular microscopy images, etc.,), what size they would look optimal at, and how many it would make sense to have in your initial template. You can of course, produce several variations if you’ll have say one template for events, with a venue displayed, another for product offers and another for new content from your hub. Calls to action should be clearly visible as clickable buttons and include action words (join, view, download etc.,) to encourage readers to act and maximise click through rates.

You’ll need HTML, (preferably responsive!) and text based templates. Mobile optimisation is key for emails, with a sizeable shift in individuals using their mobile devices to read and interact with this channel, in the past few years. However, before you invest too much time optimising, check what proportion of your subscribers are opening your emails this way. Also, note that if you are using a responsive template, much of the optimisation will be automatic across devices.
Regardless of whether you have a responsive template in place, you’ll need to keep your subject line between 25-30 characters for mobile, to display correctly without being cut off. Additionally, call to actions should be centred, high-up in the email, clearly visible on your device and have enough space around them so readers do not click multiple links at once. Importantly, note if you use a pre-header — a short line of text to provide context and act as a lead-in for your subject line, you can significantly improve engagement.
Finally, there’s a legal bit — you must include your fully registered company contact details and an unsubscribe option in all emails,to comply with global data laws.

Lead nurturing and cadence

As mentioned previously, it’s really important to know the personas of your customers, and their typical journey to purchase. If you are at the early stages of setting up a company, you may not have this knowledge to hand and you can use your email marketing and other channels to help feed data into this.

New lead that you capture through gated content, or at an exhibition, typically need some time to develop trust in your brand, and have sufficient product awareness before they commit to purchase, or can become qualified as sales leads. As such, you need to have a clear plan for your e-campaign to send content that enables this conversion.

Here are some key questions to ask yourself, before we move on to the next stage of content planning:
What would develop kudos and trust in your brand at the early stages of your e-campaign?
To provide an example — if a cohort of your subscribers are researchers in a specific field – for example immunology, this could be a content piece on a newly discovered immunology pathway with input from a pre-eminent person in the field who is a current customer, or details of your companies attendance at a high-profile immunology conference or, alternatively, a link to a high-impact peer review publication featuring your product.
Ask yourself — how can you introduce your product in a way that would appeal to your subscriber and solve their problems or enhance their work?
Describe how you can solve a research or technical problem for your subscriber to create the context and need for your product and service.

Email cadence, or how often you contact your customers is important to factor when you schedule your campaign. You don’t want to bombard your subscribers with information that results in annoyance and a rise on unsubscribes. However, you want to make sure you contact them enough to ensure that brand awareness is maintained. Bi-monthly emails may be a good starting point. Above all, the key is to send valuable and relevant content and keep your eye on KPI’s for engagement and unsubscribes, to see what is working. Subsequently, you can then adjust your content plan.

In our next post, we’ll discuss email content, layouts, A/B testing, KPI’s and metrics.

Finally, good luck with your email marketing campaigns!
If you need help with your email marketing Get in touch with us now

Onyva Scientific Marketing Journey

Our journey, as a scientific marketing agency

Onyva The Agency launched in September 2015, as a specialist scientific marketing agency. Founded by our Managing Director, Dr. Seema Sharma, our aim was to provide marketing excellence for life sciences, medical and technical fields. Since then, we’ve had an exciting journey working with several clients in diverse fields. These include medical diagnostics, scientific publishing, software and biotech, to date.
It’s been a busy and creative time at Onyva. To give you a flavour, here’s a selection of some of the things we’ve done for our clients over the past year:

What’s been keeping us busy…

  • 9 bespoke cell culture kit label designs
  • 6 content marketing articles
  • 5 e-mail campaigns (beta-testing software launch, medical product marketing)
  • 5 medical, software and life sciences marketing flyers
  • 3 medical infographics
  • 2 medical and life sciences company branding projects
  • 2 biotech white papers
  • 1 e-mail platform consultation, integration and launch
  • 1 medical PR release
  • 1 web redesign and content creation
  • 1 life sciences catalogue
  • 1 medical case study video

and a whole lot more!

Scientific Marketing

The feedback we have to date suggests we grasped technical product concepts quickly. Clients stated that this saved them time in explaining concepts, and their campaigns benefitted from this understanding. This was particularly valued for content creation, infographic design and targeted email campaigns. We’ve always ensured the latter were tailored to our clients customer base, taking time to discuss individual customer personas and messaging.

‘Onyva The Agency has provided concise, targeted and well crafted articles for the Mendeley Careers website: the content has bolstered the site’s reputation as well as its Search Engine Optimisation. Seema is a consummate professional and a pleasure to work with.’ – Dr. Christian DeFeo, Product Marketing Manager – Mendeley | Elsevier.

During the last year, our clients have varied considerably. We have worked with start-ups, possessing no marketing infrastructure, who are at a preliminary stage of establishing their brand, product and customer base. In contrast, our marketing agency has also helped established companies, founded over a century ago. As a result, we have had to take a highly adaptive approach to our clients. Critically, we’ve always taken time at the start of a project to assess a client specific needs. We’ve communicated this in depth with our partners, to ensure we focus on the right marketing channels with content relevant to their phase of growth.

Seema Sharma Founder and MD‘Since our launch, we have worked successfully to bring a diverse range of marketing solutions to our clients in the life sciences, tech and scientific fields. We look forward to the year ahead, with the aim to provide the best possible scientific marketing services.’ –
Seema Sharma, Founder and MD, Onyva The Agency.

If you need scientific or tech marketing expertise in 2018 — let’s talk
e: info@onyva-agency.com T: +44 1223 790557

SEO Checklist

Navigating SEO Checklist Infographic

SEO is an iterative process. As such, you need to keep abreast of multiple ranking factors, and their potential weighting in proprietary search engine algorithm updates to make changes that matter. Our infographic provides a straight-forward SEO checklist into tactics and resources, to ensure you’ve got the key things covered.

SEO in the B2B scientific sector

Navigating SEO in a B2B setting for product marketing in the life sciences, biotech, medical or tech fields is business critical. Although, it comes with it’s own unique challenges, versus B2C or retail sectors. You’ll likely be including very similar technical terminology to your competitors, therefore, will need to experiment and use innovative ways to ensure you rank ahead.

Key steps in your SEO plan

If you are at the early stages of formulating an SEO plan, here are some key questions to ask:

    • What are your goals for SEO, and how much budget do you have to assign to it?
    • What are customers searching for, to find your product or services?

If the answer here is “we are not sure,” or “we are subjectively guessing what it is,”, you will need to dedicate time for search term and keyword research. When you’re marketing B2B, as a life sciences, biotechnology, medical or tech company, you’ll undoubtedly have considerable in-house expertise. As a result, it can be tempting to second guess and assume you know how a customer will behave.
Whilst your specialist knowledge can serve you well, we’ve encountered many instances where clients have been surprised to learn how their users are finding their products. Remember, subtle differences and variations in keywords can have a profound impact on SEO. Furthermore, keyword research tools (e.g Google Keyword Planner , Moz’s Keyword explorer and SEM Rush, to name a few, can be a huge help. Tie these in with information from search term reports from PPC, Google Trends , or other similar tools and you have a great start.
One issue you may face in a B2B environment with specialised products, is a lack of search volume for definitive data. One approach here would be to supplement data with direct user interactions from surveys.

Some key questions and points to consider when optimising your SEO strategy and content:

  • Based on your research what keywords do you want to rank highly for?
  • What are competitors ranking highly for?
  • Are you ensuring you use your SEO research to drive your online content marketing and distribution plan? (NB: it should be this way around).
  • Will your content help you earn inbound links? Take a look at whose linking to your competitors – would they link to your content as well?
  • Do you have a social media plan to share content, and drive users back to your site?
  • How are you going to measure success? What metrics are key?
  • Have you ensured you’re using Google Analytics to track traffic and sources? Here’s a useful guide for 2020 interface set up from Website Planet.
  • Have you got your on-page SEO optimised? Meta-descriptions are critical as Google matches searches based on this content and displays them in SERPS. Also consider, the slug, keyword density, and readability factors (sub-heading distribution, paragraph structure, use of active voice and transition words etc.,)
  • Are you just launching your new site? Have you got the site technical basics covered to ensure search engines trust your site? (SSL certificate, HTTPS, optimised speed of page delivery, mobile-version, privacy policy, cookie opt-in, Robots.txt, Search engine SiteMap.XML, verified postal address and a custom 404 page etc.,).

Still need more help with implementing website SEO? We offer a comprehensive service to help improve search rankings,combined with technical content production. Get in touch with our team now.

Marketing services SEO
B2B marketing, biotech marketing, Life sciences marketing, search engine optimisation, SEO services, SEO tactics, tech marketing,
New Report Technology Advances

Pharma & Biotech Industry Report: Mergers, Acquisitions and Technology Advances

Our new biotech industry report: Free to download

In our free new industry report, we give a year’s retrospective on mergers, acquisitions and technology advances. We focus specifically on the Pharmaceutical, Biotechnology and Medical (PBM) sectors in 2016. Our specialist life science marketing consultants provide a concise summary of key developments during the year. In addition, we include a useful visual summary M&A reference chart. Furthermore, emerging technologies that have driven partnerships and growth are also covered. Some examples of the latter include CART-Cell therapies and CRISPR genome editing.

See the full report

CRISPR Technology Blog

Groundbreaking Biotechnology Advances: CRISPR

CRISPR technology allows for the precise, efficient, and flexible editing of genomes, from bacteria to humans. Consequently, this has tremendous implications in diverse industries. The applications span from basic research, drug development and validation, curing genetic disease in vivo to agriculture and biofuels.
Although, the gene-editing potential of CRISPR-Cas9 was first reported three years ago [1], it was in 2015 that it moved out of academia and into the commercial world. There was significant interest from big pharmaceutical companies. Novartis announced collaborations with leading CRISPR technology companies, Intellia and Caribou, hoping to make strides in immuno-oncology and drug discovery/development. AstraZeneca jumped into the game by partnering with academic and private institutions also eyeing the technology’s potential for drug validation. Finally, Bayer entered into a joint venture with CRISPR Therapeutics AG to discover, develop and commercialize new therapeutics for a variety of diseases and to develop in vivo therapeutics for genetic diseases.
Juno Therapeutics, a leader in immunotherapy, partnered with Editas Medicine with plans to use CRISPR technology for their work on the development of CAR-T therapies for cancer. Outside of the pharmaceutical space, DuPont also entered into a collaboration with Caribou, with a specific interest in agriculture.
Amid the frenzy of commercial interest, a patent dispute over the technology is in progress. Additionally, the potential of the technology to ‘easily’ perform germ-line editing has also created significant controversy with some fearing its use to make ‘designer babies’. Whether for scientific, financial or ethical reasons, CRISPR will not be leaving the headlines anytime soon.

See our full report here

[1] Jinek, M et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012 Aug 17;337(6096):816-21. PMID: 22745249

Biotechnology advances blog

Groundbreaking Biotechnology Advances: A year retrospective

Welcome to our new blog series ‘Groundbreaking Biotechnology Advances: A year retrospective’. We’ll be featuring some of the key emerging technologies that have gained significant momentum in the biotechnology, medical and pharma fields in the past year. First up we’ll be taking a look at liquid biopsy…

– With sequencing technologies becoming cheaper and more sensitive, minimally invasive liquid biopsies are becoming a reality for the detection, monitoring and treatment of cancer. The method relies on the capture and sequencing of DNA from circulating tumor cells (CTCs). An alternative source is from DNA floating freely after release by dying tumor cells (ctDNA), found in the bloodstream or urine.
Commercially available tests, such as those offered by Guardant Health and Trovagene, are already in use in late stage cancer patients to monitor their response to treatment and have shown favorable results. In addition, several high-profile studies were published in the last couple of years showing the feasibility and utility of liquid biopsies.
They have the potential for providing oncologists with:

  • 1. Quicker tests
  • 2. A non-invasive procedure
  • 3. Cost savings

As a result, it wasn’t a surprise that 2015 showed an increase in commercial interest in the area. This was seen from new biotech firms, as well as established diagnostics and pharmaceutical companies. Qiagen is making deals with pharmaceutical companies to use its already available tests for companion diagnostics. Roche acquired CAPP Medical and invested in Foundation Medicine, a company currently offering tumor sequencing, to help develop its liquid biopsy test. Other major players in the field include Genomic Health, Pathway Genomics, RainDance Technologies and Biocept, to name a few.
Many of these companies predict to launch a series of new tests in the next few years. Furthermore, sequencing technology leader, Illumina announced in January 2016 its plans to launch a new company called GRAIL, to focus specifically to this mission.
Given all of the attention and investment that liquid biopsies are getting, it would not be surprising that in the next 5-10 years, such testing would become part of everyone’s routine physical. In fact, some estimates predict the cancer application liquid biopsy market will reach $1.9B by 2020 [1].

Ref: [1] Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets. January 2016. ReportLinker.com

Back to main Onyva Blog – for marketing tips and tech news

New Year: A great time to review marketing tactics

Happy New Year Marketing
We’re laying out the welcome mat for 2016 here at Onyva and are excited about the challenges it brings. It’s a great time to review your current marketing strategy. A quick check-in on the best ROI from last years budget can definitely put you ahead for this one. Are you using the most appropriate channels that work for your sector? Got your SEO in check? Using Email marketing effectively? Creating shareable content? Making the most of Social? Confident with your brand representation? If you need help with a review and tangible actions —
Why not contact our team now